Revised: Fisher & Paykel Healthcare to Announce Full Year Results

Fisher & Paykel Healthcare Corporation Limited (NZSX:FPH, ASX:FPH) announced today that it now intends to release on Tuesday, 26 May its financial results for the year ended 31 March 2009. The release will be issued at approximately 10:00am NZST, 8:00am AEST (6:00pm USEDT, Monday 25 May).

Fisher & Paykel Healthcare will host a conference call to review the results and to discuss the outlook for the 2010 financial year. The conference call is scheduled to begin at 1:00pm NZST, 11:00am AEST (9:00pm USEDT, Monday 25 May) and will be broadcast simultaneously over the Internet.

To listen to the webcast access the company’s website at Please allow extra time prior to the webcast to visit the site and download the streaming media software if required. An online archive of the event will be available approximately two hours after the webcast and will remain onsite for two weeks.

Intending participants may register for the conference call prior to the event, using this link: Once registered, participants will be assigned a conference Passcode and user PIN. On the day of the conference registered participants can dial in to one of the numbers below and use their codes for instant access to the conference. Alternatively, dial in to one of the numbers below a few minutes prior to the scheduled call time and identify yourself to the operator:

New Zealand Toll Free              0800 449 118
Australia Toll Free                      1800 500 686
USA Toll Free                          1866 369 4113
International                          +61 3 9221 4420

An audio replay of the conference call will be available approximately 60 minutes after the call and will be accessible for two weeks at +61 3 9221 4752, access code 043633.

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company visit

Contact: Michael Daniell MD/CEO on +64 9 574 0161 or Tony Barclay CFO on +64 9 574 0119.